Organized by Messe Düsseldorf (Shanghai) Co., Ltd., Medical Fair China (MFC) 2026 successfully concluded on August 22, 2026, at Suzhou International Expo Center. Under the theme “From Innovation to Application: Driving Medical Transformation and Global Expansion,” the exhibition brought together medical device companies, healthcare institutions, research organizations, industry associations and professionals from China and abroad.

This year, MFC brought together 320 medical device companies and innovative organizations, attracting 17,486 professional visitors, healthcare representatives, experts, academics and industry professionals over three days. The exhibition also saw a significant increase in international participation, with the number of overseas professional visitors and buyers doubling from the previous year and accounting for 6% of total attendance. Visitors from 48 countries and regions attended the show, including buyer groups from Germany, the UK, Australia, Canada, Kazakhstan, South Korea, India, Dubai, Malaysia, Indonesia and Romania. They met with Chinese medical device companies to discuss product procurement, market access, distribution partnerships and international business opportunities, providing more opportunities for Chinese companies to explore overseas markets.

As the only satellite event of MEDICA—the world’s largest medical trade fair—in China and a member of MEDICARE ASIA, MFC continues to leverage Messe Düsseldorf’s global healthcare industry network to facilitate international exchange and industry cooperation.

Ms. Evian Gu, General Manager of Messe Düsseldorf (Shanghai) Co., Ltd., said: “We are delighted to see that this year’s MFC has reached a new high in internationalization, which fully demonstrates the strong appeal of China’s medical device innovation to the global market. Looking ahead, MFC will continue to leverage its advantages as an international platform, further deepen international buyer outreach and market matchmaking services, help more Chinese companies efficiently connect with global opportunities, and accelerate the implementation and commercialization of more innovative outcomes, injecting new momentum into the mutual benefit and win-win development of the global medical industry.”

Driving Innovation from Concept to Application Across Specialized Zones

In 2026, MFC further enhanced its specialized zones to address the evolving needs of healthcare innovation and application. Covering key areas including in vitro diagnostics (IVD), home healthcare, medical manufacturing, minimally invasive and interventional technologies, and medical consumables, the exhibition brought together leading companies to showcase innovative technologies, products and solutions, highlighting the industry’s continued transition from innovation to real world application.

IVD Zone: From Precision Diagnostics to Multi-Scenario Applications

In vitro diagnostics (IVD) play a critical role in early disease screening, precision diagnosis and treatment decision-making. This year, MFC placed greater emphasis on its dedicated IVD Zone, bringing together more than 60 companies across molecular diagnostics, point-of-care testing (POCT), immunodiagnostics, biochemical testing, AI-assisted analysis and home testing. The zone showcased innovations spanning the spectrum from laboratory and clinical diagnostics to home health applications.

In precision and molecular diagnostics, Anbio Biotech, Nanjing Healed and HymonBio presented technologies and solutions for genetic testing, nucleic acid testing and precision diagnostics. In rapid and point-of-care testing, Drophil Biotech, Sun Biotech, QL Biotech and Anhui DeepBlue Medical Technology showcased solutions designed to improve testing efficiency and enable faster decision-making across diverse healthcare settings. Meanwhile, Getein Biotech, Kanghua Biotechnology, Human Metabolomics, Synsorbio, Hebei Xinle, Hangzhou Testsea, B&E, Sejoy, Bioland and Biobase featured intelligent testing technologies, laboratory equipment and related solutions.

Representative innovations on display further highlighted the expansion of IVD technologies toward greater precision, intelligence and home-based applications. These included Nanjing Healed’s four-in-one circular RNA test kit for depression and Sejoy’s new-generation 4G cloud-based smart blood glucose meter, demonstrating how IVD innovation is evolving across different application scenarios, from precision diagnostics to digital health management.

Home Healthcare Zone: Bringing Healthcare from Hospitals into the Home

As population ageing, chronic disease management and demand for home-based healthcare continue to grow, MFC placed greater emphasis on the home healthcare sector, covering health monitoring, home care, rehabilitation and health management. Companies including Zepu, Hanvon Health, Pango, Lumi, Jinfu, Aofeite, Lifemed, Berrcom, Exanovo and ADSS, as well as Pioneer, showcased a diverse range of products and solutions designed to support healthcare beyond traditional clinical settings.

Exhibitors showcased innovative solutions for health monitoring, home care and rehabilitation, supporting more convenient everyday health management. The zone highlighted the continued expansion of healthcare services beyond hospitals into homes and communities, reflecting the industry’s growing focus on real-world needs and applications.

Medical Manufacturing Zone: Advanced Manufacturing Enabling Medical Device Innovation

Innovation in medical devices depends not only on end products, but also on advances in precision manufacturing, critical components and materials. The MFC Medical Manufacturing Zone covered precision machining, smart manufacturing, advanced materials, fluid technology and critical components, bringing together companies including Chung Pak, Huayi Precision, AccuPath, Eco Polymer, Kamoer, Nisus, MISHPREC, Consensic and Zhejiang Hongchang Machinery.

Exhibitors showcased technologies in precision machining, medical materials, fluid control, automation and critical components, supporting greater precision, efficiency and stability in medical device manufacturing. The zone also highlighted the growing integration of advanced manufacturing with medical device R&D and production.

Meanwhile, the Minimally Invasive & Interventional Zone showcased innovative technologies and advanced medical devices for minimally invasive diagnosis and treatment. The Medical Consumables Zone featured a wide range of products for surgery, nursing, treatment and everyday healthcare, highlighting their role in enhancing clinical efficiency, supporting patient safety and improving healthcare delivery.

Many exhibitors noted that MFC offered more than a platform for showcasing innovation, providing valuable opportunities to connect directly with healthcare institutions, research organizations, distributors and international buyers.

Xu Zheng, Head of the Kunshan Service Center at LINGKE ULTRASONICS, said: “MFC offers a professional atmosphere and brings together well-matched exhibitors and visitors. It gave us a valuable opportunity to meet industry customers and potential partners, while gaining a better understanding of market needs and trends. We look forward to continuing our involvement in MFC and collaborating with more industry partners in the future.”

Cheng Wenhui, Head of International Marketing at Shandong Ande Health, said: “MFC is an important link between Chinese innovation and international markets. The show gave us a good opportunity to present our products and meet overseas customers. We hope to reach more international markets through MFC.”

From exhibitors to professional visitors, MFC provided a valuable opportunity for both sides of the industry to meet face to face and gain a better understanding of the market. Mehrad, Purchasing Manager at Lian Trade, Iran, said: “This was my first time at Medical Fair China in Suzhou, and I was impressed by the wide range of medical device products. The show gave me a good opportunity to meet Chinese companies and explore potential cooperation.”

High-Level Concurrent Events Explore New Opportunities for Medical Innovation and Industry Development

Alongside the exhibition, MFC hosted a series of professional forums, seminars and industry events, bringing together 120 experts and speakers from healthcare institutions, research organizations, industry associations, medical technology companies and international markets, and attracting 1000 industry attendees. Discussions covered key topics including AI, wearable technologies, home healthcare, medical procurement, high-quality hospital development and international market expansion, strengthening connections between emerging technologies, clinical needs and real-world applications.

As a key event dedicated to the future of healthcare innovation, the 2026 FTR4H – Future for Healthcare Forum, organized by Wearable Technology AG, brought together experts and industry representatives from China and abroad to explore AI and data analytics, wearable technologies and home healthcare. Dr. Iyappan Gunasekaran from the for Cardiovascular Health Engineering (COCHE), Hong Kong, shared insights into the application of AI and data technologies in healthcare, while Eric Zhang from Haleon discussed developments in health technology. Speakers from Yisheng Innovation Technology, AP Infosense, Solventum and Bosch, among others, shared perspectives on digital health, wearables, healthcare data and innovative applications. Through keynote presentations and panel discussions, the forum explored how AI, sensors and digital technologies can drive innovation in healthcare delivery and accelerate the transition from technology development to real-world applications.

Addressing international healthcare markets and the global expansion of Chinese medical device companies, the Kazakhstan Medical Procurement Forum brought together healthcare and procurement representatives to discuss market demand, medical device procurement and international cooperation. Ali Nurgozhayev, Director of the Institute of Health Economics and Financing, and Assem Imandossova, Executive Director of the Kazakhstan Healthcare Managers Association, shared insights into the Kazakh healthcare market and procurement landscape. The forum also facilitated direct dialogue between international buyers and Chinese companies on market access, product demand and potential partnerships, supporting business expansion in Central Asia.

As innovation increasingly connects technology development with clinical practice, the 2nd Seminar on Empowering High-Quality Hospital Development through Innovative Technologies, organized by the China Association for the Promotion of Rehabilitation Technology Transformation and Development, focused on hospital discipline development under the 15th Five-Year Plan, medical technology innovation and research translation. Discussions explored how innovative technologies can better address clinical needs and accelerate the adoption of new solutions, while strengthening collaboration among hospitals, research institutions and medical device companies.

In addition, the 2026 Emergency Medical Alliance Series – Empowering Integrated Medical and Elderly Care through Fine Medical-Engineering Management, hosted by the Chinese Hospital Association and supported by Messe Düsseldorf (Shanghai), was held concurrently in Hall A. Hospital and healthcare professionals discussed medical-engineering collaboration, refined management and integrated medical and elderly care. Their participation further reflected MFC’s strong reach among targeted professional audiences, particularly healthcare institutions, providing more direct connections between medical device companies and end users.

From future healthcare technologies and international medical procurement to home testing, consumer healthcare and hospital innovation, MFC’s concurrent events brought together professionals from across the healthcare industry. Attendees also praised the practical value of the forums. Mrs. Yuan, Deputy Director of Operations at Jianxin Medical, said: “The forum covered timely topics and gave us useful insights into healthcare supply chains and new ideas for future cooperation.”

The exhibition and forums together connected innovation, clinical needs, industry applications and global markets, supporting the adoption of new technologies and closer industry collaboration.

With MFC 2026 now concluded, the exhibition not only showcased the latest innovations in medical technology, but also strengthened connections between technological innovation, clinical applications, industry collaboration and international cooperation, providing a professional and efficient platform for Chinese and international medical device companies to explore partnerships and share new opportunities.

The next edition of Medical Fair China (MFC 2027) will take place on August 19-21, 2027, at Suzhou International Expo Center. MFC looks forward to once again bringing together partners from across the global healthcare industry, showcasing more cutting-edge technologies and innovative solutions, and exploring new pathways from innovation to application.

Meanwhile, MEDICA 2026, the world’s leading medical trade fair, will take place from November 16 to19, 2026, in Düsseldorf, Germany. The global medical community will gather there to exchange insights on emerging trends and forge new pathways for international cooperation.

Medical Taiwan 2026, organized by the Taiwan External Trade Development Council (TAITRA), concluded today (June 27) at TWTC Hall 1. The three-day exhibition attracted visitors from 63 countries, with Japan, Thailand, Vietnam, the Philippines, and South Korea ranking among the top five visitor markets. This year’s exhibition also drew a strong international presence, with nearly 20 buyer groups organized by industry associations from around the world. Notably, first-time buyer groups included medical device manufacturers, medical software industry associations, and hospital associations from emerging and strategic markets such as Saudi Arabia, Australia, Hungary, India, and Vietnam, underscoring Medical Taiwan’s growing international appeal as a leading platform in Asia for smart healthcare trade and industry exchange.

Taiwan continues to strengthen its global competitiveness through its comprehensive industrial supply chain, spanning semiconductors, precision instruments, and electronic manufacturing, while integrating advanced medical device manufacturing with AI-driven innovation. During the exhibition, the One-on-One Procurement Meetings facilitated approximately 580 business-matching sessions between 107 international buyers from 46 countries—including Japan, Brazil, Israel, Hungary, the UK, Kazakhstan, Egypt, the US, Vietnam, Australia, Germany, Mexico, Romania, and Nigeria—and nearly 200 exhibitors. The meetings are projected to generate US$168.7 million in business opportunities, further underscoring the competitiveness of Taiwan’s smart healthcare industry on the global stage.

Exhibitors responded positively to this year’s exhibition, noting significant increases in both the number and diversity of international buyers compared with previous editions. Buyers also expressed strong interest in smart healthcare solutions, digital health technologies, and high-value medical devices. The strong demand highlights growing international interest in Taiwanese medical technologies and reinforces Medical Taiwan’s role as a key platform for international buyers to explore industry trends and develop partnerships across Asia.

Themed activities held throughout the exhibition were also well received. The “Taiwan Patent GO” pavilion, established by the Taiwan Intellectual Property Office (TIPO), showcased innovative patented technologies in precision medicine, AI-enabled healthcare, and assistive devices. The pavilion attracted buyers from Singapore, Qatar, the US, India, and Romania, who engaged in discussions on technology collaboration and market expansion.

The “RX FOR FUTURE Forum,” which focused on global healthcare trends, featured Professor Bruce Leff of Johns Hopkins University, a pioneer of the Hospital-at-Home (HaH) model, along with experts from Japan, Israel, and Australia. The speakers shared insights into home-based medical care and smart nursing. Experts highlighted AI, telemedicine, and digital health as key technologies driving the transformation of healthcare delivery at home. The “Digital Healthcare Pavilion” further showcased these trends through scenario-based demonstrations of Taiwan’s integrated hardware and software capabilities, attracting in-depth inquiries from buyers from Mexico and Chile, as well as representatives of the Australian Medical Software Industry Association.

Furthermore, the M-novator Demo Day, held on the first day of the exhibition, successfully connected domestic and international startups with medical institutions and investors. The event attracted financial institutions and investment firms, including Fubon Financial Holding, Biopro Bioteck, and CDIB Capital, facilitating connections between innovative technologies and capital markets while strengthening international collaboration in Taiwan’s smart healthcare sector.

TAITRA stated that Medical Taiwan 2026 successfully brought together players from the global healthcare supply chain and fostered cross-sector innovation, further reinforcing Taiwan’s position as a leading hub for smart healthcare collaboration in Asia. Looking ahead, Medical Taiwan will continue to serve as a premier platform for smart healthcare trade and innovation, working with international partners to promote sustainable industry development and create new opportunities for global collaboration and business growth.

AI for pre-surgery assessment, wearable rehabilitation technologies and live robotic gait demonstrations put the practical application of healthcare innovation at the centre of Medical Fair Asia, Medical Manufacturing Asia and the inaugural RehaCare Asia, held at Marina Bay Sands from 9 to 11 September.

The three co-located events brought together 13,854 attendees from 73 countries and regions, with over 40% overseas visitors, alongside 1,000 exhibitors from 40 countries and regions. From Singapore General Hospital’s work on the PEACH chatbot for pre-surgery assessment to discussions on manufacturing, cybersecurity and market access, the three events connected clinical needs with the expertise required to bring new technologies into wider use.

The MotusAcademy × RehaCare Asia Leadership Forum drew a full house. During the session, St Luke’s Hospital and Robotimize signed a memorandum of understanding to test, refine and integrate rehabilitation robotics into clinical practice.

The inaugural ASEAN Care Readiness Index 2026, commissioned by Messe Düsseldorf Asia and launched during the events, highlighted the challenge of translating healthcare ambition into practice. Among 300 healthcare and MedTech leaders surveyed across six Southeast Asian markets, 94% considered their organisations prepared for the next three to five years, yet 54% identified technology implementation capability as a barrier to future readiness.

Lars Wismer, Managing Director of Messe Düsseldorf Asia, shared: “The technology is advancing quickly, but implementation must keep pace. Over the three days, we have seen what that means in practice: technology must fit clinical workflows, support healthcare professionals, work beyond the hospital and be viable to manufacture and scale. These are no longer separate conversations. They determine whether innovation ultimately reaches patients.”

Medical Fair Asia: AI moves closer to everyday clinical use

At Medical Fair Asia, practical applications of AI and connected healthcare showed how technology is beginning to move from experimentation into clinical workflows. At the Paradigm Shifts in Healthcare Seminar 2026, Singapore General Hospital shared its experience developing PEACH (PErioperative AI Chatbot) to support pre-operative assessments. The tool was developed around SGH’s institutional protocols for a clinic handling around 120 patients each day. Meanwhile, at the Future for Health (FTR4H) Conference Asia 2026, Quanta Computer explored continuous monitoring through wearable and ambient sensing across hospitals and homes.

Healthcare institutions and technology companies from Taiwan shared applications spanning AI-assisted cardiovascular and stroke detection, antimicrobial resistance prediction, generative AI to reduce administrative workloads, telehealth and remote monitoring. The sessions also examined how hospitals, homes and communities can be better connected, alongside pathways to clinically validate and commercialise locally developed MedTech.

The Innovation Partner Showcase zone brought emerging applications onto the exhibition floor, with Singapore-developed technologies from institutions including SUTD, the NUS Biorobotics Lab and Singapore Polytechnic, spanning wearable rehabilitation technologies, lightweight exoskeletons, AI enabled healthy ageing and AR/VR rehabilitation.

Sim Sovannara, CEO, Central Medical Services Co., Ltd, Cambodia shared that “To strengthen healthcare in Cambodia, we must look beyond our borders, learn from other healthcare systems and build meaningful international partnerships. Medical Fair Asia gives us access to new technologies, modern equipment and practical solutions that can improve patient care while supporting the continued development of our healthcare institutions.”

Medical Manufacturing Asia: A good technology still must become a viable product

At Medical Manufacturing Asia, implementation started further upstream: how to turn new technology into products that can be manufactured, commercialised and deployed safely at scale.

At the Medical Manufacturing Forum, A*STAR SIMTech / AIMfg examined barriers preventing manufacturers from scaling AI, including fragmented data and complex manufacturing environments. A*STAR Innovation Factory was introduced, focused on the decisions required to take technologies from prototype to manufacturable product, including whether companies should build capabilities internally, outsource, partner or acquire. Its central message was straightforward: a great technology does not automatically make a great product.

Market Entry Briefings added another consideration for companies looking to expand across the region. Regulatory strategy, intended use, product classification and the licences required to manufacture, import or distribute products can all affect how and when a technology reaches individual markets.

Medical Manufacturing Asia also named Nelipak Healthcare Packaging Pte Ltd the winner of its 2026 Marketing Excellence Award, with Toki Automation Pte Ltd receiving the Special Recognition Award.

Mr. Steven Toy, Chairman, Singapore Precision Engineering and Technology Association (SPETA) shared, “Medical Manufacturing Asia reflects the strength of the partnership between SPETA and Messe Düsseldorf Asia, combining our industry knowledge and local manufacturing network with the exhibition’s international reach. This edition has provided Singapore companies with an important platform to demonstrate their precision-engineering and advanced-manufacturing capabilities, connect with the global MedTech community and explore new business opportunities. We look forward to continuing to develop MMA in line with the evolving needs of the industry.”

RehaCare Asia: Recovery moves beyond hospital walls

At the inaugural RehaCare Asia, the question was not only what rehabilitation technology can do, but whether it can fit into the lives of patients and the work of healthcare professionals.

Speakers at the From Pilot to Practice: Closing Asia’s Rehabilitation Technology Adoption Gap forum stressed that clinical efficacy alone does not determine adoption. Patient goals, workflow fit, affordability, technical support, maintenance and whether technology can be used at home or in the community all matter.

Adjunct Associate Professor Dr Loh Yong Joo, Senior Consultant, Rehabilitation Medicine at Tan Tock Seng Hospital, highlighted the physical demands placed on therapists and the potential for robotics to reduce that burden while enabling patients to undertake more intensive rehabilitation. His message was clear: “Rehabilitation shouldn’t stop after discharge. It should continue in the community.”

The shift was reinforced at the Living Longer, Living Better Seminar, held in collaboration with Frost & Sullivan. Panellists described care moving from episodic treatment towards a connected journey spanning prevention, diagnosis, acute care, rehabilitation and community care, with technology helping to decentralise services and extend existing healthcare capacity. Another discussion challenged healthcare providers to design for the older adults of tomorrow, as today’s middle-aged population will enter later life with different expectations around independence, lifestyle, and how and where they receive care.

Practical application was also on display through Locomotor Therapy in Practice, which brought together robotic gait training, body weight-supported treadmill training and overground rehabilitation in a live patient demonstration.

Jenny Shih, an exhibitor with OPPO Medical’s Global Sales and Marketing team, said: “With so many medical exhibitions taking place around the world, the quality of the support team and the range of services available to exhibitors are crucial. Medical Fair Asia and RehaCare Asia gave us a strong platform to stay connected with our clients and business partners, while helping us stand out within a competitive international market.”

The co-located format brought clinical teams, researchers and technology suppliers together with manufacturing and market-access expertise, connecting participants across the development and adoption of healthcare technologies. The debut of RehaCare Asia extended that focus to rehabilitation, independence and care in homes and communities.

Looking ahead, Medical Fair Thailand and RehaCare Asia will take place in Bangkok from 8 to 10 September 2027. Medical Fair Asia, Medical Manufacturing Asia and RehaCare Asia will return to Singapore from 13 to 15 September 2028.

For updates on future editions, visit the official websites for Medical Fair Asia, Medical Manufacturing Asia and RehaCare Asia.

Addressing Revenue Cycle Inefficiencies at the Source

Revenue cycle teams across the country continue to lose significant time and financial resources managing downstream problems — including claim denials, missing documentation, authorization failures, inaccurate charge capture, and delayed payments. Oracle Health is responding to these systemic challenges by embedding AI upstream across the full revenue cycle spectrum: from scheduling and financial clearance through clinical documentation, charge capture, billing, and payment processing.

The goal, as articulated by Oracle Health, is to identify risks early, streamline routine workflows, and connect clinical, financial, payer, and operational data before these gaps translate into payment delays and revenue loss.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, spoke directly to the strategic intent behind the initiative: “AI gives us an opportunity to prevent revenue cycle problems before they lead to denials and delayed payments. Oracle Health is delivering a comprehensive revenue cycle solution that brings AI across the front, middle, and back office, connecting clinical and financial workflows from the first patient interaction through payment. This can help healthcare organizations reduce administrative work and revenue leakage, get paid faster, and strengthen their financial stability so they can stay focused on delivering excellent patient care.”

Connecting Fragmented Systems Through Native AI

A core challenge facing many healthcare organizations today is the fragmentation of clinical, financial, payer, provider, and operational activities across disconnected systems and manual processes. These disconnects create inefficiencies, reimbursement delays, and mounting administrative burdens.

Oracle Health’s AI revenue cycle approach addresses this by connecting workflows across patient access, clinical documentation, patient accounting, contract intelligence, payment operations, enterprise analytics, and financial management — all within existing Oracle Health infrastructure. Organizations can adopt these embedded AI capabilities at their own pace, without the disruption of wholesale system replacement.

New Embedded AI Capabilities

The newly announced AI capabilities, planned for general availability in the coming months, span five key areas of the revenue cycle:

Prior Authorization — Checks coverage, retrieves and pre-fills documentation requirements, attaches clinical evidence, coordinates authorization activities, and supports payer interactions to reduce authorization-related delays and denials.

Clinical Document Quality Integrity — Reviews reimbursement-related documentation, identifies gaps, and surfaces contextual recommendations to improve documentation and coding quality.

Charge Capture and Integrity — Analyzes clinical and reimbursement context, including modifiers and service details within charge review workflows, to limit revenue leakage and optimize reimbursement outcomes.

Medical Coding for Professional Fees — Analyzes clinical documentation and patient context to surface coding recommendations within existing workflows, supporting reimbursable claim readiness.

Appeal Management — Analyzes remittance data, identifies payment variances, and automates the creation of appeal packets when an appeal decision is made, helping reduce turnaround times.

Integration with Enterprise Financial Operations

As part of its planned product direction, Oracle Health intends to extend the connectivity of AI revenue cycle workflows into broader enterprise financial operations. This includes financial reconciliation, revenue accounting, treasury management, and analytics through platforms such as Oracle Fusion Cloud Applications. The intent is to enable health systems to connect reimbursement activity, financial operations, and enterprise analytics to support more informed operational and financial decision-making.

Strengthening Financial Stability Across Healthcare Organizations

The overarching aim of these AI revenue cycle capabilities is to help healthcare organizations reduce administrative overhead, limit revenue leakage, accelerate payments, and maintain the financial stability required to sustain quality patient care. By embedding intelligence across both the clinical and financial sides of the revenue cycle, Oracle Health is positioning its portfolio as a connected, end-to-end solution for revenue performance optimization.

Converse Health was founded in 2023 by Louis Sallerson, Val Zinchenko, and Adam Teitelman to build custom administrative workflows for independent medical practices in dermatology, women’s health, pain medicine, and orthopedics. The company raised $1.3 million and grew to serve dozens of practices.

“Operations leaders are being forced to bolt AI onto existing systems and buy solutions one task at a time, which is unmanageable. Practices want to redesign their workflows and decision-making around AI agents,” said Alex Cohen, CEO and founder of Hello Patient. “Our AI agents carry real conversations so every call gets answered and patients’ needs are handled from start to finish. Converse Health brings the same automation to the back office, and the busywork stops landing on staff so they can focus on care instead of administrative tasks.”

Practices lose patients at the front desk. Up to 42% of patient calls and texts go unanswered during busy hours. The back-office work that follows the call is just as costly. A referral arrives as a fax that someone opens, classifies, matches to a patient, and files before any care gets scheduled. A patient calls to schedule a follow-up, hits voicemail, calls back, and gets a busy signal. Staff spend the day playing phone tag with patients, referring offices, and payers, and the appointment never gets booked.

Most of the administrative work in a practice follows a similar workflow: answer the call, route the fax, book the follow-up the chart asked for, send the payer what it wants. Hello Patient now automates the majority of work across a practice’s operations, giving staff time back for the patient standing in front of them. Practice leaders also get a single view of how the operation actually runs and one company accountable for it.

“The agents have been a great addition to our practice,” said Jeff Craven, COO at Ortho1, an orthopedic group running this back-office technology across 100% of their incoming referrals, successfully scheduling 57% of engaged patients and processing referrals in half the time. “We were inundated with incoming referrals. The agent has shouldered a significant portion of our proactive outreach without requiring any additional support from our staff.”

Converse Health provides an AI layer that reads and writes to EHRs and delivers automation in days. The acquisition transforms these back-office capabilities into an agentic workflow using Hello Patient:

• Referral and fax intake – Agents open incoming faxes, identify what each one is, match it to a patient record or create one, and file the document where staff expect to find it.
• Chart-driven follow-up – Agents read the clinical note and incoming labs, find the patients whose follow-up window has passed without an appointment, and reach out to book them.
• Authorization paperwork – Agents pull patient and procedure details from the chart, compose the request for authorization, and route it to staff for review before it reaches the payer.
• Records and registration – Agents complete registration from a phone call, retrieve imaging, and fulfill medical records requests.

“Hello Patient already sits at the front door of thousands of practices, so Converse Health becomes a natural extension,” said Sallerson, who joins Hello Patient as product leader for back-office and specialty workflows. “Together, we can deliver these back-office capabilities at real scale and cover a practice’s operations end-to-end with one AI layer. Doctors and their staff keep the exam room. We’ll convert more patients at the front desk and handle the paperwork before the visit and the follow-up after it.”

Converse Health capabilities are available as part of the Hello Patient agentic AI platform now. Read the full story on our website.

LiGHT 26, the UK’s only trade show dedicated to high-end lighting specification, returns to the Business Design Centre in Islington, London, on the 18th and 19th of November 2026, bringing together the lighting and design community for two days of product discovery, expert insight and valuable industry connection.

Whether specifying an upcoming project, searching for new suppliers, discovering the latest technologies or simply looking to stay ahead of emerging trends, LiGHT 26 provides a unique opportunity to explore the very best of the lighting industry – all under one roof.

Since launching in 2022, LiGHT has quickly established itself as a key date in the calendar for architects, interior designers, lighting designers, engineers, consultants and specifiers, offering a dedicated platform to discover new products, meet leading manufacturers and connect with the people behind some of the most innovative lighting projects.

For two days, the Business Design Centre will become a hub of creativity, collaboration and conversation, with hundreds of leading architectural and decorative lighting brands showcasing the latest products, technologies and solutions. From cutting-edge lighting systems and controls to decorative fittings, technical innovations and smart building technologies, visitors will have the chance to experience new ideas first-hand and discover products before they are specified on future projects.

Returning for LiGHT 26, the Technical Zone will provide a dedicated area for brands specialising in lighting controls, emergency lighting, OEM components, lamps, gear, connected technologies and more. Reflecting the growing importance of intelligent and integrated lighting solutions, the zone offers visitors the chance to explore the technologies driving the future of sustainable and efficient design.

Beyond the exhibition floor, LiGHT 26 will deliver an inspiring programme of talks and discussions, bringing together influential voices from across the lighting, architecture and design communities. Curated by [d]arc media, the [d]arc thoughts talk programme will explore the latest challenges, opportunities and ideas shaping the future of lighting, with speaker announcements for this and the splinter talks programme in the Associations Lounge to follow.

Adding another creative dimension to the show, planning is already well underway for the LiGHT 26 Art Installation, which will once again bring together lighting, creativity and design to create a memorable centrepiece for visitors to experience during the exhibition. Further details will be revealed in the coming months, with visitors invited to experience this unique feature during the show.

Networking remains at the heart of the LiGHT experience. From conversations with exhibitors and industry experts to informal catch-ups with peers, the event provides the perfect environment to build relationships, exchange ideas and discover new opportunities. The popular late-night drinks reception will also return, offering visitors and exhibitors the chance to continue conversations in a more relaxed social setting after the first day of the show.

LiGHT 26 also marks the first edition of the exhibition under the ownership of Messe Frankfurt UK, following the acquisition of LiGHT Expo London. Now part of Messe Frankfurt’s internationally recognised portfolio, the exhibition will continue to build on the strong foundations established since its launch, while retaining the community-focused identity that has made LiGHT such a valued event within the lighting industry. [d]arc media will continue to support the exhibition through promotional activity and the curation of its content programme.

Simon Albert, CEO of Messe Frankfurt UK, said: “LiGHT has become one of the most important meeting places for the UK lighting specification community, and we’re delighted to welcome the industry back this November. As the first edition under Messe Frankfurt UK, LiGHT 26 will continue to deliver what visitors and exhibitors value most – exceptional brands, inspiring content and meaningful connections – while benefiting from the international reach and expertise of the wider Light + Building portfolio.”

With thousands of professionals expected to attend, LiGHT 26 is set to once again bring together the brands, ideas and individuals shaping the future of lighting. Completely free to attend, it offers an unmissable opportunity to discover new products, gain fresh inspiration and connect with the wider lighting community.

If lighting plays a role in your projects, LiGHT 26 should be in your diary.

Register now for free and be part of the UK’s leading event dedicated to lighting specification.

InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the successful deployment of InterSystems TrakCare® across iKang Outpatient，the premium healthcare services brand of iKang Healthcare Group. The TrakCare deployment establishes a unified electronic health record (EHR) solution, resolving issues such as data duplication and data silos, and lays the foundation for iKang Healthcare Group to realize its health management vision.

iKang Healthcare Group is a leading AI-powered digital healthcare management platform in China, leveraging cloud-based medical big data services. Through its portfolio of brands, iKang provides high-quality health management and medical services to corporate clients, families, and individuals, including health screenings, disease testing, dental care, private physician services, workplace healthcare, vaccinations, anti-aging programs, and rehabilitation services.

A Single Source of Truth​ for iKang Outpatient’s Facilities

The TrakCare unified EHR solution features a single user interface, a single codebase, and a single high-performance data platform that stores and shares all patient records. Data requires entry only once to become instantly available across the entire system. TrakCare also supports modular deployment to meet the needs of different clinics.

Across iKang’s nationwide outpatient network, TrakCare establishes a single source of truth​ and a unique patient identification system. This enables seamless data continuity, ensuring the integrity and consistency of patient records. By standardizing clinical workflows, medical record templates, and foundational data standards, TrakCare supports tiered management strategies and enables unified and efficient national operations.

Additionally, TrakCare will achieve deep integration with iKang’s Health Checkup Cloud. This enhances the consolidation of health checkup and other clinical data, supporting iKang’s vision of comprehensive, full-lifecycle health management.

Key Benefits

Currently, TrakCare has been deployed in 28 outpatient facilities, with full completion expected this year. The deployment of TrakCare delivers significant value to iKang Outpatient, enhancing both clinical outcomes and operational management.

1. Clinical Impact

The visualization of patient data allows physicians to gain a holistic view of client health, thereby enhancing diagnostic continuity and precision. Leveraging TrakCare, iKang Outpatient has achieved:

(1) Standardized clinical workflows, ensuring uniform compliance across all outpatient facilities, thereby effectively mitigating medical risks; and

(2) Standardized care delivery processes, optimizing the end-to-end patient journey, improving operational consistency, and enhancing patient convenience and satisfaction.

2. Managerial Impact

TrakCare empowers iKang Outpatient to implement refined operational management. Based on a consolidated data foundation, the group can conduct more precise business analysis and strategic optimization, leading to better resource allocation.

”InterSystems is committed to providing clean, healthy data for better healthcare,” said Luciano Brustia, Managing Director of InterSystems Asia Pacific. “We are thrilled to support iKang Healthcare Group’s vision of delivering full lifecycle health care to its clients a goal made possible through unified, clean, and healthy data.”

With a workforce of over 7,500 employees across 250+ locations, and expansion across India as well as international markets including Sri Lanka, South Africa, and Dubai, Neuberg Diagnostics has been steadily modernising its people operations to support scale, consistency, and real-time visibility. As the organisation moves towards a projected workforce strength of 10,000 employees, managing multi-location teams, diverse employee categories, and complex compliance requirements has made unified HR infrastructure increasingly critical.

Following the implementation of OfficeNet’s AI-enabled HR ecosystem, Neuberg Diagnostics has achieved a significant operational shift, reducing manual HR tasks by up to 90% while improving process efficiency and workforce visibility across locations. Rather than relying on fragmented systems, the organisation has transitioned towards an integrated, AI-enabled HR framework designed to streamline workforce management across functions.

OfficeNet now serves as the digital backbone for key HR operations, enabling automation-led processes across attendance, payroll, recruitment, and workforce analytics. The platform’s AI-powered attendance system with facial recognition-based check-ins has improved workforce tracking across locations, particularly in diagnostic centres where traditional biometric infrastructure is limited.

In addition, geo-enabled workforce tracking and mobile-first access have strengthened visibility for field-based teams, while automated payroll and compliance workflows have improved accuracy and reduced manual dependencies. The system also leverages AI-driven resume parsing to accelerate hiring cycles and predictive HR dashboards that provide real-time insights into workforce distribution across locations, roles, and business units.

A significant portion of Neuberg Diagnostics’ workforce, nearly 60% operates in field and distributed roles, including doctors, scientists, technicians, and collection agents. For such a structure, real-time coordination and mobility-driven HR processes are critical. OfficeNet’s mobile-enabled ecosystem allows employees to manage attendance, travel, expenses, and incentive claims seamlessly, improving transparency and reducing administrative delays.

Sonali Chowdhry, CEO of OfficeNet, added, “As organisations scale rapidly, HRMS platforms are evolving from administrative systems into integrated operational ecosystems. For dynamic and fast-growing industries such as healthcare and diagnostics, real-time workforce visibility, automation, and process intelligence are becoming critical. We are pleased to support Neuberg Diagnostics with a flexible and scalable platform that simplifies complex workforce operations while enabling smarter and more efficient people management.”

With a growing clientele of over 500 brands, including LG Electronics, Havells, Prince Pipes, Bajaj Auto, JBM Group, LT Foods, Wings Pharma, Patanjali Ayurveda, Vishal Mega Mart, Amber Electronics, ACGL Goa, and ITC Hotels across healthcare, manufacturing, retail, and enterprise sectors, OfficeNet continues to strengthen its position as a trusted HRMS partner for large-scale organisations managing complex and distributed workforce ecosystems.